What the company does
IN8bio, Inc., a clinical-stage biotechnology company, is focused on developing new therapies for the treatment of cancers, including solid tumors using genetically modified, autologous, allogeneic gamma-delta T cells. The company is headquartered in New York, New York.
What the weekly tape is saying
INAB closed the latest completed week at 1.43 USD. The 4-week return is -4.0% and the 12-week return is -28.5%. Trend Signal is inactive, Market Dynamics is 0.49. Setup signature: Risk-first tape with a 19/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 1.77 USD
- Vs Trend Line
- -19.3%
- Fair Value
- 15.99 USD
- Vs Fair Value
- -91.1%
- 52W High
- 2.73 USD
- 52W Low
- 1.17 USD
- Drawdown
- -47.6%
- Range Position
- 16.7%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 0 weeks
- 52W Active Weeks
- 0
- 52W Active Breadth
- 0.0%
- Sector Scope
- US Healthcare
- Sector Rank
- 656 of 1033
- Sector Percentile
- 36.5%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
US Healthcare
- Tracked Peers
- 100
- 4W Rank
- - of 100
- Avg 1W
- 0.8%
- Avg 4W
- 3.5%
- Trend Breadth
- 33.0%
- Positive MD
- 41.0%
US Biotechnology
- Tracked Peers
- 100
- 4W Rank
- - of 100
- Avg 1W
- 4.9%
- Avg 4W
- 1.7%
- Trend Breadth
- 46.0%
- Positive RS
- 47.0%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- 0.49
- 4W MD Change
- 249.8%
- Relative Strength
- -37.87
- 4W RS Change
- 8.5%
- Expectation
- Negative
- Probability
- 43.91%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 175.7K
- 13W Average
- 345.8K
- 52W Average
- 627.1K
- Vs 13W
- 0.5x
- Vs 52W
- 0.3x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 11.7%
- 52W Volatility
- 15.6%
- Upside Weeks
- 25
- Downside Weeks
- 26
- Downside Breadth
- 50.0%
- Avg Gain / Loss
- 10.1% / -9.4%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- NASDAQ
- Country
- US
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- USD
- Market Cap
- 17.7M
Opportunity signals
- Market Dynamics is positive on the latest completed week.
Risk signals
- Trend Signal is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- The share remains more than 20% below its 52-week high.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 1.43 USD | -1.4% | 1.77 USD | 15.99 USD | 0.49 | -37.87 | 175.7K | Off |
| 5 Jun 2026 | 1.45 USD | -22.5% | 1.78 USD | 16.36 USD | 0.41 | -36.44 | 410.8K | Off |
| 29 May 2026 | 1.87 USD | 12.0% | 1.78 USD | 16.76 USD | 0.30 | -24.35 | 332.8K | Off |
| 22 May 2026 | 1.67 USD | 12.1% | 1.78 USD | 17.35 USD | -0.06 | -32.83 | 411.9K | Off |
| 15 May 2026 | 1.49 USD | -5.7% | 1.80 USD | 17.88 USD | -0.33 | -41.37 | 278.5K | Off |
| 8 May 2026 | 1.58 USD | 5.3% | 1.82 USD | 18.49 USD | -0.44 | -39.76 | 276.4K | Off |
| 1 May 2026 | 1.50 USD | 0.0% | 1.83 USD | 18.93 USD | -0.61 | -41.93 | 367.7K | Off |
| 24 Apr 2026 | 1.50 USD | 4.2% | 1.86 USD | 19.37 USD | -0.68 | -43.37 | 338.8K | Off |
| 17 Apr 2026 | 1.44 USD | 3.6% | 1.89 USD | 19.64 USD | -0.55 | -46.89 | 321.4K | Off |
| 10 Apr 2026 | 1.39 USD | -3.5% | 1.91 USD | 19.84 USD | -0.28 | -47.66 | 214.9K | Off |
| 2 Apr 2026 | 1.44 USD | 2.1% | 1.93 USD | 20.06 USD | 0.01 | -45.26 | 195.2K | Off |
| 27 Mar 2026 | 1.41 USD | -29.5% | 1.96 USD | 20.27 USD | 0.24 | -46.18 | 686.7K | Off |
| 20 Mar 2026 | 2.00 USD | 5.8% | 1.98 USD | 20.52 USD | 0.38 | -29.07 | 484.1K | Off |
| 13 Mar 2026 | 1.89 USD | 9.9% | 1.99 USD | 20.74 USD | 0.45 | -37.08 | 305.0K | Off |